Evidence map›Paper›PMID 20068046›Full record

ArticleThe Journal of biological chemistry2010

Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis.

Wei Hu, Ruijuan Xu, Wei Sun, Zdzislaw M Szulc, Jacek Bielawski, Lina M Obeid, Cungui Mao

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Sphingolipid metabolism and regulated cell death in malignant melanoma.Apoptosis : an international journal on programmed cell death · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease.Journal of cardiovascular development and disease · 2022
    Review
  15. Review
  16. Article
  17. Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wei HuDepartments of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Ruijuan Xu
Wei Sun
Zdzislaw M Szulc
Jacek Bielawski
Lina M Obeid
Cungui Mao
Medical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASEP20RR017677 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MAO, CUNGUI · 2002 to 2011
$23.4M
Sphingosine Phosphate Role in InflammationR01GM062887 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OBEID, LINA M · 2001 to 2009
$2.1M
Alkaline Ceramidase and Sphingolipid SignalingR01CA104834 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MAO, CUNGUI · 2004 to 2008
$1.1M
NCI NIH HHS R01 CA104834NCI NIH HHS R01CA104834NCRR NIH HHS P20 RR017677NCRR NIH HHS P20RR017677NIGMS NIH HHS R01 GM062887NIGMS NIH HHS R01GM062887
6 · The paper itself

Abstract

Ceramides with different fatty acyl chains may vary in their physiological or pathological roles; however, it remains unclear how cellular levels of individual ceramide species are regulated. Here, we demonstrate that our previously cloned human alkaline ceramidase 3 (ACER3) specifically controls the hydrolysis of ceramides carrying unsaturated long acyl chains, unsaturated long-chain (ULC) ceramides. In vitro, ACER3 only hydrolyzed C(18:1)-, C(20:1)-, C(20:4)-ceramides, dihydroceramides, and phytoceramides. In cells, ACER3 overexpression decreased C(18:1)- and C(20:1)-ceramides and dihydroceramides, whereas ACER3 knockdown by RNA interference had the opposite effect, suggesting that ACER3 controls the catabolism of ULC ceramides and dihydroceramides. ACER3 knockdown inhibited cell proliferation and up-regulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1). Blocking p21(CIP1/WAF1) up-regulation attenuated the inhibitory effect of ACER3 knockdown on cell proliferation, suggesting that ACER3 knockdown inhibits cell proliferation because of p21(CIP1/WAF1) up-regulation. ACER3 knockdown inhibited cell apoptosis in response to serum deprivation. ACER3 knockdown up-regulated the expression of the alkaline ceramidase 2 (ACER2), and the ACER2 up-regulation decreased non-ULC ceramide species while increasing both sphingosine and its phosphate. Collectively, these data suggest that ACER3 catalyzes the hydrolysis of ULC ceramides and dihydroceramides and that ACER3 coordinates with ACER2 to regulate cell proliferation and survival.

Indexed as

Alkaline CeramidaseApoptosisCarcinoma, Squamous CellCell DivisionCeramidasesCeramidesCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p21Down-RegulationEndothelial CellsGene Expression Regulation, EnzymologicHeLa CellsHumansHydrolysisKeratinocytesMuscle, Smooth, VascularACER3 protein, humanAlkaline CeramidaseCDKN1A protein, humanCeramidasesCeramidesCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p21dihydroceramideRNA, MessengerRNA, Small Interfering

Identifiers

PMID20068046
PMCPMC2832947
OpenAlexW2118261235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.